Philips International B.V.

Philips Lung Suite – 01

Philips Lung Suite – 02

March 28, 2022

New installs of Philips Lung Suite real-time 3D imaging resolution in Belgium, France, Israel, and the UK spotlight rapidly-growing international scientific curiosity within the firm’s built-in all-in-one lung most cancers prognosis and remedy imaging resolution

Solution helps precision prognosis and minimally-invasive remedy in a single room

Clinical trials for minimally invasive remedy procedures utilizing superior imaging from Philips Lung Suite begin with profitable first instances

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a world chief in well being know-how, as we speak supplied an replace on the rising international scientific curiosity in its progressive lung most cancers prognosis and remedy resolution – Philips Lung Suite – which is underlined by its fast roll-out with new scientific companions. Some of the brand new innovating associate websites are: Royal Brompton Hospital – London UK; Hôpital Erasme – Brussels, Belgium; Ziekenhuis Oost-Limburg (ZOL), Genk Medical Center – Genk, Belgium; Carmel Medical Center – Haifa, Israel. Rouen University Hospital – Rouen, France can also be planning to begin utilizing the innovation. Several healthcare suppliers have already efficiently identified their first sufferers utilizing Lung Suite, which works together with the corporate’s Image Guided Therapy System – Azurion.

Lung most cancers is the primary explanation for most cancers dying worldwide, claiming the lives of 1.8 million individuals per 12 months [1]. More than 60% of lung most cancers sufferers are identified at a late stage, lowering their odds of survival [2]. Philips Lung Suite is a revolutionary 3D real-time imaging platform that addresses the necessity for earlier precision prognosis and minimally-invasive remedy with an all-in-one platform that allows medical doctors to carry out biopsy, ablation, marking of lesions, and/or thoracic surgical procedure procedures in the identical room, permitting sufferers to be each identified and handled. Its capacity to find and characterize small-sized lesions may considerably improve future lung most cancers care.

Story continues

“Philips Lung Suite has been proven to extend the accuracy of lung most cancers biopsy procedures, bettering outcomes for sufferers and providing the potential to instantly deal with early-stage lung most cancers sufferers,” stated Karim Boussebaa, General Manager, Image Guided Therapy Systems at Philips. “These new companions add to our quickly increasing international ecosystem of scientific companions who’re pushing innovation ahead, with of the aim of providing sufferers prognosis and minimally-invasive remedy in a single process, bettering affected person outcomes and their high quality of life.”

No nodule can cover
Philips Lung Suite offers superior real-time 3D imaging with augmented fluoroscopy on the corporate’s Image Guided Therapy Systems – akin to Azurion, mixed with devoted software program. With Philips’ Cone Beam CT imaging, the X-ray detector rotates across the affected person to generate a CT-like picture in round 5 seconds, offering clinicians with a high-resolution 3D view of the goal lesion and different anatomical buildings. This permits the clinician performing the biopsy process to be regularly guided by high-quality real-time imaging to advance a catheter in direction of the lesion by means of a bronchoscope. Once achieved, its place might be confirmed in real-time utilizing the identical imaging modality, and a biopsy pattern might be taken.

“In the fast-growing world of intraoperative imaging, cone-beam CT stays the gold commonplace for augmented fluoroscopy and lesion affirmation. Using Lung Suite, no nodule can cover, no matter anatomical place or radiologic attribute, making it a invaluable instrument for each prognosis and future ablation procedures,” stated Dr. Amir Abramovich, MD., Director of Interventional Pulmonology on the Carmel Medical Center in Haifa, Israel.

“Cone-beam CT is the essential step in direction of concentrating on sub-20 mm nodules and a vital instrument for the transition in direction of bronchoscopic microwave ablation of peripheral lung lesions,” stated Professor Shah Pallav, MD., guide respiratory doctor at Royal Brompton Hospital in London, UK.

“The superior cone beam CT imaging mixed with augmented fluoroscopy of Philips Lung Suite offers us the boldness to soundly attain and biopsy difficult-to-access peripheral lung nodules,” stated Maarten Criel, MD., Pulmonologist at ZOL Genk Medical Center, Belgium.

Dr. Kelvin Lau, guide and lead thoracic surgeon at St Bartholomew’s Hospital, London, efficiently identified and handled lung most cancers sufferers utilizing cone beam CT for biopsy, bronchoscopic microwave ablation and for precision image-guided surgical procedure, multi functional process, throughout preliminary scientific trial. Advanced imaging with Philips Lung suite is used throughout procedures for real-time 3D picture steering and affirmation. Additional scientific trials at varied hospitals are anticipated to begin quickly.

An October 2021 paper within the Journal of Bronchology & Interventional Pulmonology authored by researchers at Radboud University Medical Center, the Netherlands, demonstrated the diagnostic potential of Lung Suite. The researchers had been in a position to elevate the diagnostic accuracy of navigation bronchoscopy from 72% to 90%. In addition, the typical whole efficient radiation dose per process was diminished by greater than half [3].

[1] https://www.who.int/news-room/fact-sheets/detail/cancer
[2] https://www.cancer.org/cancer/lung-cancer/detection-diagnosis-staging/survival-rates.html
[3] Journal of Bronchology & Interventional Pulmonology: October 2021 – Volume 28 – Issue 4 – p 262-271 doi: 10.1097/LBR.0000000000000783

For additional info, please contact:

Joost Maltha
Philips Global Press Office
Tel: +31 6 10 55 8116
E-mail: joost.maltha@philips.com

Fabienne van der Feer
Philips Image Guided Therapy
Tel: + 31 622 698 001
E-mail: fabienne.van.der.feer@philips.com

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a number one well being know-how firm centered on bettering individuals’s well being and well-being, and enabling higher outcomes throughout the well being continuum – from wholesome residing and prevention, to prognosis, remedy and residential care. Philips leverages superior know-how and deep scientific and shopper insights to ship built-in options. Headquartered within the Netherlands, the corporate is a frontrunner in diagnostic imaging, image-guided remedy, affected person monitoring and well being informatics, in addition to in shopper well being and residential care. Philips generated 2020 gross sales of EUR 17.3 billion and employs roughly 78,000 workers with gross sales and companies in additional than 100 nations. News about Philips might be discovered at www.philips.com/newscenter.



Source link

#Philips #expands #community #scientific #companions #set #commonplace #care #early #prognosis #remedy #lung #most cancers

By Seth A. Dunbar

Seth Dunbar leads clinical research study operations and quality & compliance. He is experienced working with teams to help drug sponsors better leverage eSource data. With 10+ years of experience Seth brings expertise developing eClinical services that integrate data and technology to help companies optimise study execution.

Leave a Reply

Your email address will not be published. Required fields are marked *